View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

CEVA, MU, NVDA, POWI, SITM, COHR, RTX, DELL, HPQ, SONYT, TM, SMP, PATK, SWK, PATK, SWK, MOV, HUN, SSL, ELAN, GSK, LIVN, OMI, SHC, BGS, MKC, TSN, UVV, CHD Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

RAYTHEON TECHNOLOGIES sees an upgrade to Slightly Positive due to a be...

The general evaluation of RAYTHEON TECHNOLOGIES (US), a company active in the Aerospace & Defense industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 3 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date January 4, 2022, the closing...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 10 05

Citigroup (C) looks to finally be rounding the corner of its transformational reconstruction. Uniform Accounting shows both the company's significant operational improvements, and that the market isn't pricing them in sustainably. That makes Citi a compelling buy. Citi has historically been a worst-in-class performer in terms of Uniform ROE, around 5% in the early 2010s, however these operational improvements have already lifted ROE towards peer levels, approaching double digit levels, and the...

Valens Research
  • Valens Research

RTX - Embedded Expectations Analysis - 2021 10 01

Raytheon Technologies Corporation (RTX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 17.1x Uniform P/E. Even at these levels, the market is pricing expectations for profitability to stabilize, but management may have concerns about free cash flow generation, segment margins, and their innovation capabilities. Specifically, management may lack confidence in their ability to maintain free cash flow generation, continue exceeding adjusted EPS expect...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 03 16

INOV has been steadily improving UAFRS-based (Uniform) ROA the past few years before the pandemic, thanks to its conversion from a dataset company to a healthcare insight software platform with significant growth opportunities. And yet the market doesn't recognize how this can continue to mean accelerating returns and growth going forward. While the company has one of the few leading healthcare insight platforms not already captured by a major player like UnitedHealthcare, and currently only...

Valens Research
  • Valens Research

RTX - Embedded Expectations Analysis - 2021 03 15

Raytheon Technologies Corporation (RTX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 16.7x Uniform P/E. Even at these levels, the market is pricing in bullish expectations for the firm, but management may have concerns about meeting their 2021 guidance, their cash on hand, and the sustainability of M&A synergies Specifically, management may lack confidence in their ability to meet their 2021 EPS and sales guidance and mitigate Raytheon Intellige...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch